ETrade Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-10,410
| Closed | -$163K | – | 830 |
|
|
2019
Q1 | $163K | Buy |
+10,410
| New | +$163K | ﹤0.01% | 785 |
|
|
2018
Q4 | – | Sell |
-9,999
| Closed | -$215K | – | 820 |
|
|
2018
Q3 | $215K | Sell |
9,999
-674
| -6% | -$14.5K | 0.01% | 776 |
|
|
2018
Q2 | $260K | Sell |
10,673
-336
| -3% | -$8.19K | 0.01% | 689 |
|
|
2018
Q1 | $188K | Buy |
+11,009
| New | +$188K | 0.01% | 729 |
|
|
2017
Q4 | – | Sell |
-13,147
| Closed | -$231K | – | 766 |
|
|
2017
Q3 | $231K | Sell |
13,147
-3,803
| -22% | -$66.8K | 0.01% | 644 |
|
|
2017
Q2 | $563K | Sell |
16,950
-643
| -4% | -$21.4K | 0.02% | 434 |
|
|
2017
Q1 | $565K | Sell |
17,593
-10,529
| -37% | -$338K | 0.02% | 410 |
|
|
2016
Q4 | $1.02M | Sell |
28,122
-8,087
| -22% | -$293K | 0.05% | 231 |
|
|
2016
Q3 | $1.67M | Buy |
36,209
+1,894
| +6% | +$87.1K | 0.08% | 152 |
|
|
2016
Q2 | $1.72M | Buy |
34,315
+12,402
| +57% | +$623K | 0.09% | 136 |
|
|
2016
Q1 | $1.17M | Buy |
21,913
+691
| +3% | +$37K | 0.07% | 171 |
|
|
2015
Q4 | $1.39M | Sell |
21,222
-514
| -2% | -$33.7K | 0.08% | 141 |
|
|
2015
Q3 | $1.23M | Sell |
21,736
-756
| -3% | -$42.7K | 0.08% | 158 |
|
|
2015
Q2 | $1.33M | Buy |
22,492
+960
| +4% | +$56.7K | 0.08% | 161 |
|
|
2015
Q1 | $1.34M | Buy |
21,532
+4,546
| +27% | +$283K | 0.08% | 163 |
|
|
2014
Q4 | $977K | Buy |
16,986
+2,668
| +19% | +$153K | 0.06% | 200 |
|
|
2014
Q3 | $770K | Buy |
14,318
+3,733
| +35% | +$201K | 0.05% | 224 |
|
|
2014
Q2 | $555K | Buy |
10,585
+4,998
| +89% | +$262K | 0.04% | 247 |
|
|
2014
Q1 | $295K | Buy |
5,587
+2,909
| +109% | +$154K | 0.02% | 273 |
|
|
2013
Q4 | $107K | Buy |
2,678
+1,192
| +80% | +$47.6K | 0.01% | 353 |
|
|
2013
Q3 | $56K | Buy |
1,486
+785
| +112% | +$29.6K | 0.01% | 413 |
|
|
2013
Q2 | $27K | Buy |
+701
| New | +$27K | ﹤0.01% | 457 |
|